Get started
Author

Yasunori Kawaguchi

Observed names: Y. Kawaguchi, Yasunori KAWAGUCHI
ORCID: 0009-0008-7756-2462
Observed ORCID: 0009-0008-7756-2462
OpenAlex ID: A5109088658
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
2024 · B. Sangro, S.L. Chan, et al. · Annals of Oncology · 412
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
2019 · Tatsuya Yamashita, Masatoshi Kudo, et al. · Journal of Gastroenterology · 245
PDF
Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study
2009 · Hirokazu Takahashi, Naofumi Ono, et al. · Liver International · 226
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
2009 · Noriko Oza, Yuichiro Eguchi, et al. · Journal of Gastroenterology · 94
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease
2010 · Yuichiro Eguchi, Toshihiko Mizuta, et al. · Journal of Gastroenterology · 79
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients
2010 · Hirokazu Takahashi, Toshihiko Mizuta, et al. · Hepatology Research · 76
Interaction between hepatitis C virus and metabolic factors
2014 · Yasunori Kawaguchi, Toshihiko Mizuta · World Journal of Gastroenterology · 70
PDF
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016
2020 · Atsushi Masamune, Kazuhiro Kikuta, et al. · Pancreatology · 65
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients
2018 · Won Young Tak, Baek-Yeol Ryoo, et al. · Investigational New Drugs · 52
Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non‐alcoholic fatty liver disease, but not in females
2008 · Eriko Ishibashi, Yuichiro Eguchi, et al. · Journal of Gastroenterology and Hepatology · 44
PDF
Pancreatic insulin and exocrine secretion are under the modulatory control of distinct subpopulations of vagal motoneurones in the rat
2012 · Tanja Babic, Kirsteen N. Browning, et al. · The Journal of Physiology · 43
Eradication of hepatitis C virus by interferon improves whole‐body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C
2009 · Yasunori Kawaguchi, Toshihiko Mizuta, et al. · Liver International · 42
Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
2011 · Hirokazu Takahashi, Toshihiko Mizuta, et al. · Journal of Gastroenterology · 40
Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation
2009 · Yuichiro Eguchi, Toshihiko Mizuta, et al. · Liver International · 32
Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients
2011 · Takumi Akiyama, Toshihiko Mizuta, et al. · World Journal of Gastroenterology · 25
PDF
Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load
2009 · Toshihiko Mizuta, Yasunori Kawaguchi, et al. · Digestive Diseases and Sciences · 24
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study
2021 · Taiga Otsuka, Tsuyoshi Shirakawa, et al. · International Journal of Clinical Oncology · 23
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
2021 · Futa Koga, Yasunori Kawaguchi, et al. · Journal of Geriatric Oncology · 22
Current management practices for HBs antigen or anti-HCV antibody positive individuals in non-hepatology departments at a university hospital
2013 · Naoko Eguchi Furukawa, Yasunori Kawaguchi, et al. · Kanzo · 19
PDF
Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C
2010 · Yumi Kobayashi, Yasunori Kawaguchi, et al. · Journal of Gastroenterology · 16
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
2024 · Tomoko Kodama, Takashi Imajima, et al. · Scientific Reports · 14
Efficacy of ezetimibe for reducing serum low‐density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non‐alcoholic fatty liver disease
2013 · Noriko Oza, Hirokazu Takahashi, et al. · Hepatology Research · 14
Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
2013 · Satoshi Oeda, Toshihiko Mizuta, et al. · PubMed · 13
Whole-body Insulin Resistance is Associated with Elevated Serum α-fetoprotein Levels in Patients with Chronic Hepatitis C
2013 · Yasunori Kawaguchi, Toshihiko Mizuta, et al. · Internal Medicine · 12
PDF
High‐dose vitamins E and C supplementation prevents ribavirin‐induced hemolytic anemia in patients with chronic hepatitis C
2007 · Yasunori Kawaguchi, Toshihiko Mizuta, et al. · Hepatology Research · 11
Works count: 74
Citation count: 1,818
H-index: 19
I10-index: 26
Year
Topic
Type